580 related articles for article (PubMed ID: 9229321)
21. [Early phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group].
Sugano K; Ota K; Taguchi T; Ogawa N; Kurihara M; Akazawa S; Ogawa M; Tominaga T; Sasaki T; Konishi T
Gan To Kagaku Ryoho; 1995 Apr; 22(5):627-37. PubMed ID: 7717714
[TBL] [Abstract][Full Text] [Related]
22. Systemic treatment options in advanced colorectal cancer: perspectives on combination 5-fluorouracil plus leucovorin.
Grem JL
Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-8-S18-18. PubMed ID: 9420016
[TBL] [Abstract][Full Text] [Related]
23. Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU.
Gamelin EC; Danquechin-Dorval EM; Dumesnil YF; Maillart PJ; Goudier MJ; Burtin PC; Delva RG; Lortholary AH; Gesta PH; Larra FG
Cancer; 1996 Feb; 77(3):441-51. PubMed ID: 8630950
[TBL] [Abstract][Full Text] [Related]
24. Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer.
Hochster H; Chachoua A; Speyer J; Escalon J; Zeleniuch-Jacquotte A; Muggia F
J Clin Oncol; 2003 Jul; 21(14):2703-7. PubMed ID: 12860947
[TBL] [Abstract][Full Text] [Related]
25. The EORTC GI group experience with high-dose infusional 5-FU in colorectal cancer.
Blijham GH
J Infus Chemother; 1996; 6(3):114-7. PubMed ID: 9229320
[TBL] [Abstract][Full Text] [Related]
26. Biochemical modulation in the treatment of advanced cancer: a study of combined leucovorin, fluorouracil, and iododeoxyuridine.
Marshall JL; Richmond E; DeLap RJ
Clin Cancer Res; 1996 Sep; 2(9):1475-80. PubMed ID: 9816323
[TBL] [Abstract][Full Text] [Related]
27. Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma.
Nogué M; Seguí MA; Saigí E; Batiste-Alentorn E; Arcusa A; Boleda M; Antón I
Cancer; 1998 Jul; 83(2):254-8. PubMed ID: 9669807
[TBL] [Abstract][Full Text] [Related]
28. Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer.
Chau I; Webb A; Cunningham D; Hill M; Waters JS; Norman A; Massey A
Br J Cancer; 2001 Nov; 85(9):1258-64. PubMed ID: 11720458
[TBL] [Abstract][Full Text] [Related]
29. Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer.
Kundel Y; Purim O; Figer A; Stemmer SM; Tichler T; Sulkes J; Sulkes A; Brenner B
Med Sci Monit; 2008 Apr; 14(4):CR190-5. PubMed ID: 18376346
[TBL] [Abstract][Full Text] [Related]
30. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the levogyre and dextro-levogyre forms of leucovorin in a phase III trial of bimonthly LV5FU2 versus monthly 5-fluorouracil and high-dose leucovorin for patients with stage II and III colon cancer (GERCOR C96.1).
Baumgaertner I; Quinaux E; Khalil A; Louvet C; Buyse M; de Gramont A; André T;
Clin Colorectal Cancer; 2010 Apr; 9(2):E5-10. PubMed ID: 20378497
[TBL] [Abstract][Full Text] [Related]
32. Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer.
Mani S; Rudin CM; Kunkel K; Holmlund JT; Geary RS; Kindler HL; Dorr FA; Ratain MJ
Clin Cancer Res; 2002 Apr; 8(4):1042-8. PubMed ID: 11948111
[TBL] [Abstract][Full Text] [Related]
33. [A cooperative late phase II trial of l-leucovorin and 5-fluorouracil in the treatment of advanced gastric cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)].
Takeda S; Taguchi T; Ohta J; Kurihara M; Abe T; Ohtani T; Yonemura Y; Ohno T; Hirabayashi N; Nakano S
Gan To Kagaku Ryoho; 1995 Jun; 22(7):903-10. PubMed ID: 7793996
[TBL] [Abstract][Full Text] [Related]
34. Investigation into the usefulness and adverse events of CDDP, 5-fU and dl-leucovorin (PFL-therapy) for advanced colorectal cancer.
Okabe S; Ishikawa T; Tanami H; Kuwabara H; Fukahara T; Udagawa M; Ootsukasa S; Arai T; Maruyama S; Murase N; Yamashita H; Iwai T
J Med Dent Sci; 2002 Jun; 49(2):77-84. PubMed ID: 12627817
[TBL] [Abstract][Full Text] [Related]
35. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
Klaassen U; Wilke H; Seeber S
J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323
[TBL] [Abstract][Full Text] [Related]
36. [Late phase II trial of high-dose l-leucovorin and 5-fluorouracil in advanced colorectal carcinoma. l-Leucovorin and 5-FU Study Group (Japan Eastern Group)].
Yoshino M; Ota K; Kurihara M; Akazawa S; Tominaga T; Sasaki T; Konishi T; Kodaira S; Kumai K; Sugano K
Gan To Kagaku Ryoho; 1995 May; 22(6):785-92. PubMed ID: 7755386
[TBL] [Abstract][Full Text] [Related]
37. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
[TBL] [Abstract][Full Text] [Related]
38. A phase I-II trial of five-day continuous intravenous infusion of 5-fluorouracil delivered at circadian rhythm modulated rate in patients with metastatic colorectal cancer.
Lévi F; Soussan A; Adam R; Caussanel JP; Metzger G; Jasmin C; Bismuth H; Smolensky M; Misset JL
J Infus Chemother; 1995; 5(3 Suppl 1):153-8. PubMed ID: 8528977
[TBL] [Abstract][Full Text] [Related]
39. Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy.
Chiara S; Nobile MT; Vincenti M; Lionetto R; Gozza A; Barzacchi MC; Sanguineti O; Repetto L; Rosso R
Cancer Chemother Pharmacol; 1998; 42(4):336-40. PubMed ID: 9744780
[TBL] [Abstract][Full Text] [Related]
40. A preliminary report of a phase II trial. UFT plus oral folinic acid as therapy for metastatic colorectal cancer in older patients. Spanish Group for the Treatment of Gastrointestinal Tumors (TTd Group).
Abad A; Navarro M; Sastre J; Marcuello E; Aranda E; Gallén M; Fernandez-Martos C; Martín C; Diaz-Rubio E
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):53-7. PubMed ID: 9348570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
